Literature DB >> 12646636

ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.

Qiang Pan-Hammarström1, Shujing Dai, Yaofeng Zhao, Iris F van Dijk-Härd, Richard A Gatti, Anne-Lise Børresen-Dale, Lennart Hammarström.   

Abstract

Class switch recombination (CSR) and somatic hypermutation (SHM) are mechanistically related processes that share common key factors such as activation-induced cytidine deaminase. We have previously shown a role for ATM (mutated in ataxia-telangiectasia) in CSR. In this paper we show that the frequency, distribution, and nature of base pair substitutions in the Ig variable (V) heavy chain genes in ataxia-telangiectasia patients are largely similar to those in normal donors, suggesting a normal SHM process. Characterization of the third complementarity-determining region in B cells from ataxia-telangiectasia patients also shows a normal V(D)J recombination process. SHM-like mutations could be identified in the switch (S) mu region (up to several hundred base pairs upstream of the S mu -S(alpha) breakpoints) in normal in vivo switched human B cells. In the absence of ATM, mutations can still be found in this region, but at less than half the frequency of that in normal donors. The latter mutations are mainly due to transitions (86% compared with 58% in controls) and are biased to A or T nucleotides. An ATM-dependent mechanism, different from that generating SHM in V genes, is therefore likely to be involved in introducing SHM-like mutations in the S region. ATM may thus be one of the factors that is not shared by the CSR and SHM processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646636     DOI: 10.4049/jimmunol.170.7.3707

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  DNA damage and repair during lymphoid development: antigen receptor diversity, genomic integrity and lymphomagenesis.

Authors:  Nahum Puebla-Osorio; Chengming Zhu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Update on the hyper immunoglobulin M syndromes.

Authors:  E Graham Davies; Adrian J Thrasher
Journal:  Br J Haematol       Date:  2010-02-23       Impact factor: 6.998

3.  Extensive diversification of IgH subclass-encoding genes and IgM subclass switching in crocodilians.

Authors:  Gang Cheng; Yang Gao; Tao Wang; Yi Sun; Zhiguo Wei; Lingxiao Li; Liming Ren; Ying Guo; Xiaoxiang Hu; Yan Lu; Xumin Wang; Guiming Liu; Chenglin Zhang; Jun Yu; Qiang Pan-Hammarström; Lennart Hammarström; Xiaobing Wu; Ning Li; Yaofeng Zhao
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  Cutting Edge: ATM Influences Germinal Center Integrity.

Authors:  Laura Nicolas; Montserrat Cols; Ryan Smolkin; Keith C Fernandez; William T Yewdell; Wei-Feng Yen; Shan Zha; Bao Q Vuong; Jayanta Chaudhuri
Journal:  J Immunol       Date:  2019-04-26       Impact factor: 5.422

Review 5.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 6.  Molecular nature of radiation injury and DNA repair disorders associated with radiosensitivity.

Authors:  Yuji Masuda; Kenji Kamiya
Journal:  Int J Hematol       Date:  2012-02-18       Impact factor: 2.490

7.  Mutations occur in the Ig Smu region but rarely in Sgamma regions prior to class switch recombination.

Authors:  Carol E Schrader; Sean P Bradley; Joycelyn Vardo; Sofia N Mochegova; Erin Flanagan; Janet Stavnezer
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

8.  Naturally occurring mutation affecting the MyD88-binding site of TNFRSF13B impairs triggering of class switch recombination.

Authors:  Maria B Almejun; Montserrat Cols; Marta Zelazko; Matias Oleastro; Andrea Cerutti; Pablo Oppezzo; Charlotte Cunningham-Rundles; Silvia Danielian
Journal:  Eur J Immunol       Date:  2013-01-18       Impact factor: 5.532

9.  The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents.

Authors:  A Stray-Pedersen; T Jónsson; A Heiberg; C R Lindman; E Widing; I S Aaberge; A L Borresen-Dale; T G Abrahamsen
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

10.  Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in Japan.

Authors:  Tomohiro Morio; Naomi Takahashi; Fumiaki Watanabe; Fumiko Honda; Masaki Sato; Masatoshi Takagi; Ken-Ichi Imadome; Toshio Miyawaki; Domenico Delia; Kotoka Nakamura; Richard A Gatti; Shuki Mizutani
Journal:  Int J Hematol       Date:  2009-08-25       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.